| Makale Türü |
|
||
| Dergi Adı | Annals of Clinical and Translational Neurology (Q1) | ||
| Dergi ISSN | 2328-9503 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 09-2025 |
| Cilt / Sayı / Sayfa | 13 / 1 / 131–143 | DOI | 10.1002/acn3.70208 |
| Makale Linki | https://onlinelibrary.wiley.com/doi/epdf/10.1002/acn3.70208 | ||
| UAK Araştırma Alanları |
Genetik
Biyokimya
Moleküler Genetik
|
||
| Özet |
| Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease. Super oxide dismutase 1 (SOD1) gene mutations cause ALS, and the D90A mutation is associated with primarily upper motor neuron (UMN) loss. Objective Our goal is to reveal the early cellular events in ALS pathology and identify potential pharmacokinetic biomarkers, using well‐defined patient populations. Methods Exosomes are isolated from serum either single or multiple time points from members of one family, who have SOD1D90A mutation, and their protein content is assessed by tandem mass‐spec proteomics. Ingenuity Pathway analysis is used to highlight cellular events that are perturbed as the disease progressed. The linear regression analysis, using ALSFRS scores of patients and the protein content, helps identify potential pharmacokinetic biomarkers, which are confirmed with the ELISA assay. Results Father, Son, and Daughter … |
| Anahtar Kelimeler |
| ALS | biomarker | exosomes | proteomics | SOD1 |
| Atıf Sayıları | |
| Google Scholar | 1 |
| Dergi Adı | Annals of Clinical and Translational Neurology |
| Yayıncı | John Wiley & Sons Inc. |
| Açık Erişim | Evet |
| ISSN | 2328-9503 |
| E-ISSN | 2328-9503 |
| CiteScore | 7,4 |
| SJR | 1,681 |
| SNIP | 1,187 |